Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid dose comparison during pediatric adenotonsillectomy
IRCT20171030037093N33Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tranexamic acid in Cardiovascular collapse, sponsored by Isfahan University of Medical Sciences. Primary endpoints: Mean arterial pressure and Heart rate. Started Apr 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on IRCT20171030037093N33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171030037093N33.